<quotes>
[1] "We have synthesized 3-{[2-(3-R-adamantan-1-yl)- 2-oxoethylidene]hydrazinylidene}-5-aryl(hetaryl)furan-2(3H)-ones by cyclization of 2-hydrazinyl derivatives of 4-aryl(hetaryl)-4-oxobut-2-enoic acids containing a pharmacophoric adamantyl fragment."
[2] "Unlike structurally related compounds [13, 2026], no β-ketohydrazone tautomers of 3a3f were detected."
[3] "(3E)-3-{[(2Z)-2-(Adamantan-1-yl)-2-oxoethyli- dene]hydrazinylidene}-5-aryl(het- aryl)furan-2(3H)-ones 4a4f as orange crystalline substances."
</quotes>

<EnglishVersionAnswer>
The study synthesized 3-{[2-(3-R-adamantan-1-yl)-2-oxoethylidene]hydrazinylidene}-5-aryl(hetaryl)furan-2(3H)-ones through cyclization of specific 4-aryl(hetaryl)-4-oxobut-2-enoic acid derivatives. These compounds exist as mixtures of Z- and E-isomeric enehydrazine tautomers in solution, and no β-ketohydrazone tautomers were found for the synthesized compounds. The cyclized products were further converted into (3E)-3-{[(2Z)-2-(Adamantan-1-yl)-2-oxoethyli- dene]hydrazinylidene}-5-aryl(het- aryl)furan-2(3H)-ones as orange crystalline substances.
</EnglishVersionAnswer>

<ChineseVersionAnswer>
该研究通过环化特定的4-aryl(hetaryl)-4-oxobut-2-enoic酸衍生物合成出了3-{[2-(3-R-adamantan-1-yl)-2-oxoethylidene]hydrazinylidene}-5-aryl(hetaryl)furan-2(3H)-ones。这些化合物在溶液中存在Z-和E-异构化的enehydrazine异构体混合物，并且未发现β-酮羟基化异构体。环化产物进一步转化为(3E)-3-{[(2Z)-2-(Adamantan-1-yl)-2-oxoethyli- dene]hydrazinylidene}-5-aryl(het- aryl)furan-2(3H)-ones，呈现出橙色结晶状物质。

</ChineseVersionAnswer>
